LUMA Vision receives FDA clearance for VERAFEYE Cardiac Visualization Platform

Our portfolio company LUMA Vision has received FDA clearance for its groundbreaking VERAFEYE™ Visualization Platform.

This catheter-based imaging system provides real-time, two- and four-dimensional, 360-degree visualization of the heart during complex cardiac procedures.

Fionn Lahart, CEO at LUMA Vision: "We are incredibly proud of this achievement and the potential impact VERAFEYE will have in areas such as cardiac arrhythmias, left atrial appendage closure and structural heart. Our team and partners have worked tirelessly alongside clinicians to develop a product that can be the future of cardiac navigation, and this FDA clearance is a testament to their dedication and expertise. We look forward to seeing the positive difference VERAFEYE will make in the lives of patients and healthcare providers alike".

The successful approval of the VERAFEYE system and catheter represents a significant step forward in cardiac imaging.

You can read the full announcement online.